InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,469.30
(
0.39%
)
US TECH 100
19,246.00
(
0.37%
)
Dow Jones
39,112.16
(
-0.76%
)
Brent Oil
84.96
(
0.91%
)
Bitcoin
61,381.50
(
-0.69%
)
Post# of 185
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

mc67

Send PM Follow Ignore
Followers 106
Posts 10171
Boards Moderated 0
Alias Born 02/25/2003

mc67

Re: None

Friday, 08/21/2020 8:08:11 AM

Friday, August 21, 2020 8:08:11 AM

Post# of 185
$RLFTF The Results


Trial 3 includes a series of 21 consecutive patients with Acute Respiratory Failure in Critical COVID-19 and multiple co-morbidities, treated with intravenous VIP.
So far, 19 out of 21 of them have survived. At the moment, August 20, 7 patients were discharged from the hospital, 7 sent to intermediate care, and 5 remain in the ICU. As often in those cases, blood oxygenation is very low and can be lethal.

As you can see below, the use of RLF-100™, dramatically improved blood oxygenation.

A promising anti-COVID drug you have probably never heard of

https://medium.com/@alexschroeti/a-promising-anti-covid-drug-you-have-probably-never-heard-of-d6cae8072da6

~ Money Making Money ~

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up